Embattled hip and knee implant maker Smith & Nephew has hit back at a report claiming that it deployed aggressive accounting ...

In a report released today, Hassan Al-Wakeel from Barclays maintained a Hold rating on Smith & Nephew (SN – Research Report), with a ...

GAMMA Investing LLC boosted its position in Smith & Nephew plc (NYSE:SNN – Free Report) by 160.0% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 2,257 ...

Patented technology further personalizes total knee arthroplasty for surgeons and patientsSmith+Nephew (LSE:SN, NYSE:SNN), ...

周一，RBC Capital维持了对Smith & Nephew PLC (SN:LN) (NYSE: SNN)的乐观展望，重申其"跑赢大市"评级和15.00英镑的目标价。 该公司的立场基于Smith & Nephew的骨科部门在中长期内实现与行业同行相当的EBIT利润率的潜力。 RBC Capital预计，如果该部门实现市场水平的增长，可能会使公司2027年每股收益(EPS)的一致预期上调超过1 ...

Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company, is proud to announce that its RENASYS EDGE Negative Pressure Wound Therapy (NPWT) System has won the Red Dot Award for Design ...

Smith+Nephew announced today that it signed a co-marketing agreement with JointVue for its OrthoSonic ultrasound device.

Smith & Nephew has announced it has revised plans to leave Hull after almost 170 years in the city, citing an increase in ...

Heartland Advisors, an investment management company, released its “Heartland Mid Cap Value Fund” third quarter 2024 investor ...

(Alliance News) - Smith & Nephew PLC has received scrutiny from an equity research firm for inflating its profit margins, The Sunday Times reported. The newspaper on Sunday reported that Dragoneye ...

Smith+Nephew (NYSE:SNN) shares were little changed Wednesday. The global medical technology company announced it had signed a co-marketing agreement with JointVue for its patented OrthoSonic™ 3D ...

The medical company announced in 2022 that it was leaving the city but now says it plans to operate in both Hull and Melton ...